Back to top

Extendicare Maintained at Buy as Solid Results and Growth Outlook Support Unchanged $38 Price Target

Analyst Tom Callaghan of BMO Capital maintained a Buy rating on Extendicare, retaining the price target of C$38.00. Tom Callaghan has given his Buy...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Expand Energy Corporation (EXE)